Paul Tudor Jones's CDTX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 44,307 shares of Cidara Therapeutics, Inc. (CDTX) worth $9.79 M, representing 0.02% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in CDTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 29,363 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Cidara Therapeutics (CDTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cidara Therapeutics (CDTX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +29,363 | Add 196.49% | 44,307 | $220.89 |
| Q3 2025 | +4,033 | Add 36.96% | 14,944 | $95.76 |
| Q2 2025 | +10,911 | New Buy | 10,911 | $48.71 |
Paul Tudor Jones's Cidara Therapeutics Investment FAQs
Paul Tudor Jones first purchased Cidara Therapeutics, Inc. (CDTX) in Q2 2025, acquiring 10,911 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Cidara Therapeutics, Inc. (CDTX) for 3 quarters since Q2 2025.
Paul Tudor Jones's largest addition to Cidara Therapeutics, Inc. (CDTX) was in Q4 2025, adding 44,307 shares worth $9.79 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 44,307 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $9.79 M.
As of the Q4 2025 filing, Cidara Therapeutics, Inc. (CDTX) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Cidara Therapeutics, Inc. (CDTX) was 44,307 shares, as reported at the end of Q4 2025.